Dipna Pharmachem Ltd vs Sun Pharmaceutical Industries Limited

A side-by-side comparison of Dipna Pharmachem Ltd (DIPNAPHARMACHEMLTD) and Sun Pharmaceutical Industries Limited (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Limited leads DIPNAPHARMACHEMLTD vs SUNPHARMA on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth11
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

19.00
P/E ratio
36.79
0.45
P/B ratio
5.35
0.00%
Dividend yield
0.86%
₹0.40
EPS
₹47.80

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

2.89%
Return on equity
13.74%
7.00%
Return on capital
17.46%
3.00%
EBITDA margin
30.33%
0.80%
Net margin
19.69%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-7.67%
Revenue CAGR (3Y)
10.03%
37.86%
Profit CAGR (3Y)
10.57%

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹12 Cr
Market cap
₹4.22L Cr
₹125 Cr
Revenue
₹58,462 Cr
₹1 Cr
Net profit
₹11,509 Cr
0.48
Debt / equity
0.06
Dipna Pharmachem Ltd
  • + ["Company has reduced debt.", "Stock is trading at 0.19 times its book value", "Company's working capital requirements have reduced from 91.1 days to 55.6 days"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 9.13%", "Company has a low return on equity of 3.93% over last 3 years.", "Promoter holding has decreased over last 3 years: -57.4%"]
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.05 times its book value"]
Dipna Pharmachem Ltd full analysis Sun Pharmaceutical Industries Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.